Michael J Breslow Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael J Breslow.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael J Breslow. Michael J Breslow is EVP Clinical R&D in VISICU INC ($EICU).
Latest Insider Trading Transactions of Michael J Breslow
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.35 | 100 | 1,035 | 388,363 | 388.5 K to 388.4 K (-0.03 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.36 | 200 | 2,072 | 388,463 | 388.7 K to 388.5 K (-0.05 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.38 | 150 | 1,557 | 388,663 | 388.8 K to 388.7 K (-0.04 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.39 | 50 | 520 | 388,813 | 388.9 K to 388.8 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.49 | 137 | 1,437 | 388,863 | 389 K to 388.9 K (-0.04 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.24 | 50 | 512 | 456,150 | 456.2 K to 456.2 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.25 | 50 | 513 | 456,200 | 456.3 K to 456.2 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.26 | 50 | 513 | 456,250 | 456.3 K to 456.3 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.27 | 13 | 134 | 456,300 | 456.3 K to 456.3 K (0.00 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.28 | 50 | 514 | 456,313 | 456.4 K to 456.3 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.29 | 100 | 1,029 | 456,363 | 456.5 K to 456.4 K (-0.02 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.30 | 250 | 2,575 | 456,463 | 456.7 K to 456.5 K (-0.05 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.31 | 50 | 516 | 456,713 | 456.8 K to 456.7 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.32 | 50 | 516 | 456,763 | 456.8 K to 456.8 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.34 | 50 | 517 | 456,813 | 456.9 K to 456.8 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.35 | 100 | 1,035 | 456,863 | 457 K to 456.9 K (-0.02 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.36 | 200 | 2,072 | 456,963 | 457.2 K to 457 K (-0.04 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.38 | 150 | 1,557 | 457,163 | 457.3 K to 457.2 K (-0.03 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.39 | 50 | 520 | 457,313 | 457.4 K to 457.3 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.49 | 137 | 1,437 | 457,363 | 457.5 K to 457.4 K (-0.03 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.53 | 50 | 527 | 389,000 | 389.1 K to 389 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.57 | 41 | 433 | 389,050 | 389.1 K to 389.1 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.72 | 50 | 536 | 389,091 | 389.1 K to 389.1 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.76 | 9 | 97 | 389,141 | 389.2 K to 389.1 K (0.00 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.80 | 200 | 2,160 | 389,150 | 389.4 K to 389.2 K (-0.05 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.85 | 50 | 543 | 389,350 | 389.4 K to 389.4 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.87 | 50 | 544 | 389,400 | 389.5 K to 389.4 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.98 | 50 | 549 | 389,450 | 389.5 K to 389.5 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.00 | 50 | 550 | 389,500 | 389.6 K to 389.5 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.01 | 50 | 551 | 389,550 | 389.6 K to 389.6 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.08 | 100 | 1,108 | 389,600 | 389.7 K to 389.6 K (-0.03 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.11 | 50 | 556 | 389,700 | 389.8 K to 389.7 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.14 | 50 | 557 | 389,750 | 389.8 K to 389.8 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.19 | 150 | 1,679 | 389,800 | 390 K to 389.8 K (-0.04 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.21 | 50 | 561 | 389,950 | 390 K to 390 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.53 | 50 | 527 | 457,500 | 457.6 K to 457.5 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.57 | 41 | 433 | 457,550 | 457.6 K to 457.6 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.72 | 50 | 536 | 457,591 | 457.6 K to 457.6 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.76 | 9 | 97 | 457,641 | 457.7 K to 457.6 K (0.00 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.80 | 200 | 2,160 | 457,650 | 457.9 K to 457.7 K (-0.04 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.85 | 50 | 543 | 457,850 | 457.9 K to 457.9 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.87 | 50 | 544 | 457,900 | 458 K to 457.9 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.98 | 50 | 549 | 457,950 | 458 K to 458 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.00 | 50 | 550 | 458,000 | 458.1 K to 458 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.01 | 50 | 551 | 458,050 | 458.1 K to 458.1 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.08 | 100 | 1,108 | 458,100 | 458.2 K to 458.1 K (-0.02 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.11 | 50 | 556 | 458,200 | 458.3 K to 458.2 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.14 | 50 | 557 | 458,250 | 458.3 K to 458.3 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.19 | 150 | 1,679 | 458,300 | 458.5 K to 458.3 K (-0.03 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 11.21 | 50 | 561 | 458,450 | 458.5 K to 458.5 K (-0.01 %) |
Dec 05 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 5,000 | 50,000 | 390,000 | 395 K to 390 K (-1.27 %) |
Dec 05 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 5,000 | 50,000 | 458,500 | 463.5 K to 458.5 K (-1.08 %) |
Nov 09 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 2,500 | 25,000 | 395,000 | 397.5 K to 395 K (-0.63 %) |
Nov 09 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 2,500 | 25,000 | 463,500 | 466 K to 463.5 K (-0.54 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.25 | 500 | 4,625 | 397,500 | 398 K to 397.5 K (-0.13 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.26 | 1,000 | 9,260 | 398,000 | 399 K to 398 K (-0.25 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.28 | 250 | 2,320 | 399,000 | 399.3 K to 399 K (-0.06 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.30 | 250 | 2,325 | 399,250 | 399.5 K to 399.3 K (-0.06 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.37 | 200 | 1,874 | 399,500 | 399.7 K to 399.5 K (-0.05 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.38 | 50 | 469 | 399,700 | 399.8 K to 399.7 K (-0.01 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.40 | 150 | 1,410 | 399,750 | 399.9 K to 399.8 K (-0.04 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.41 | 50 | 471 | 399,900 | 400 K to 399.9 K (-0.01 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.42 | 50 | 471 | 399,950 | 400 K to 400 K (-0.01 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.25 | 500 | 4,625 | 466,000 | 466.5 K to 466 K (-0.11 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.26 | 1,000 | 9,260 | 466,500 | 467.5 K to 466.5 K (-0.21 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.28 | 250 | 2,320 | 467,500 | 467.8 K to 467.5 K (-0.05 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.30 | 250 | 2,325 | 467,750 | 468 K to 467.8 K (-0.05 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.37 | 200 | 1,874 | 468,000 | 468.2 K to 468 K (-0.04 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.38 | 50 | 469 | 468,200 | 468.3 K to 468.2 K (-0.01 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.40 | 150 | 1,410 | 468,250 | 468.4 K to 468.3 K (-0.03 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.41 | 50 | 471 | 468,400 | 468.5 K to 468.4 K (-0.01 %) |
Nov 07 2006 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.42 | 50 | 471 | 468,450 | 468.5 K to 468.5 K (-0.01 %) |